TENFU (06868) Confirms No Injection of IPO Proceeds to Chinese Subsidiaries by Taiwan Shareholders in H2 2025, Full Compliance with Cross-Strait Investment Regulations

Stock News
01/22

According to an announcement from TENFU (06868), investments by Taiwanese investors (including individuals and enterprises) in the People's Republic of China, whether direct or indirect and conducted through companies they control, are subject to approval from Taiwan's Investment Commission. Under the cross-strait investment regulations, such investments require prior approval from the Investment Commission; however, an exception allows for post-investment filing within six months if the total cumulative investment by all Taiwanese investors in a single Chinese entity does not exceed US$1 million. As disclosed in the prospectus, the company has several Taiwanese founders, namely Mr. Li Ruibe and Mr. Zeng Mingshun, along with 81 original Taiwanese investors, who are required to comply with these regulations when injecting the proceeds from the company's listing on the Main Board of The Stock Exchange of Hong Kong Limited into its Chinese subsidiaries. During the six-month period from July 1, 2025, to December 31, 2025, the company did not inject any listing proceeds into its Chinese subsidiaries. The company is pleased to announce its full compliance with the aforementioned cross-strait investment regulations throughout this period.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10